Revogene ® Carba C assay (formely GenePOC™ Carba Assay) is a multiplex nucleic 29 acid-based in-vitro diagnostic test intended for the detection of carbapenemase producing-30
INTRODUCTION 52
Carbapenemase-producing Gram-negative bacteria (CP-GNB) [Enterobacterales (CP-53 E), Pseudomonadaceae (CP-Pa) and Acinetobacter sp. (CP-Ab)] have increasingly been 54 reported worldwide (1, 2) . Carbapenem-resistance may be the result of combined mechanisms 55 of both outer-membrane permeability defect (e.g., porin defect) and non-carbapenemase -56 lactamases (e.g., acquired or overexpressed chromosome-encoded cephalosporinase, and 57 extended-spectrum--lactamases) and carbapenemase production (1) . The most clinically-58 relevant carbapenemases belong either to Ambler classes A, B (metallo--lactamases; MBLs) 59 or D [carbapenem hydrolyzing class D -lactamases (CHDL; oxacillinases] (3). The Ambler 60 class A carbapenemases include the worldwide disseminated KPC-type enzymes, and to a lesser 61 extend GES, SME, IMI, NMC-A, and FRI-1 variants (4). MBLs are divided into 3 main groups 62 such as IMP-, VIM-and NDM-types (3,5). CHDLs mostly belong to the (i) OXA-48 group in 63
Enterobacteriaceae (including a growing number of variants) (1), (ii) OXA-23, OXA-24/-40, 64 detection (21) . Culture of rectal swab specimens followed by confirmation testing are long, and 77 often not compatible with rapid implementation of reinforced hygiene measures (22) . 78
Molecular based techniques such as PCR, and whole genome sequencing remain the gold 79 standard for the precise identification of carbapenemase genes (22, 23) . Molecular methods are 80 now available for detecting carbapenemase genes from bacterial cultures but also directly from 81 clinical specimens in less than an hour (22) . Several assays are commercially available. Some 82 require DNA extraction from rectal swabs specimen prior to amplification such as the PCR-83 based Amplidiag R Revogene ® Carba C assay. It is still debated whether these enzymes are or not carbapenemases 128 (41,42). For example, OXA-163 is considered as a carbapenemase by the CLSI, although from 129 an enzymatic point of view with respect to imipenem, these variants are not carbapenemases 130 (43), but their nucleotide sequence is however too similar to the blaOXA-48 gene to be 131 distinguished by most molecular detection assays (24,28,30,33). Revogene ® Carba C assay has 132 this particular advantage of distinguishing these blaOXA-48 variants. Indeed OXA-163-producers 133 hydrolyze extended-spectrum cephalosporins and are most prevalent in countries such as South 134
America, but they need to be individualized as such and not be considered as genuine CPE. All 135 the tested IMP-variants were correctly identified with Revogene ® Carba C assay, even those 136 that are not detected by Xpert Carba (Cepheid) such as IMP-2, IMP-8, IMP-11, and IMP-14 or 137 by NG-test Carba5, immunochromatographic assay, which misses IMP-14 (30,33,44). In 138 multiple carbapenemase-producers, all resistance determinants were correctly identified. None 139 of the non-carbapenemase producers nor non-targeted carbapenemases yielded positive PCR 140 results. 141
Using this strain collection (n=118), the overall sensitivity and specificity were 100 % 142 [95% confidence intervals (95%CI) = 95.0% -100%] and 100% [95%CI = 83.9% -100%] for 143 the detection of CPE, respectively (Table 1) . Extrapolating these results to the global French 144 CPE epidemiology, the Revogene ® Carba C assay may be able to detect 99.28% (9555/9624) 145 of the CPEs identified by the F-NRC between 2012 and 2018, missing only 69 CPEs (2 GES-146 5; 10 OXA-23; 2 TMB-1; 1 SME-4; 54 IMI, and 1 FRI-1 producers (data not shown) (Table 4) . 147
Detection of CP-Pa. Concerning Pseudomonadaceae, all KPC-, VIM-and NDM-148 producers were perfectly detected (Table 2) , however only 15/17 IMP producers were detected. 149
Two very rare IMP variants IMP-31 and IMP-46 were not detected. As claimed by the 150 manufacturer, other carbapenemases such as GES-like carbapenemases (GES-2, GES-5), GIM-151 1, AIM-1, SPM-1, DIM-1 and OXA-198 were not detected ( The Revogene ® Carba C assay showed excellent sensitivity and specificity for the five 171 most common carbapenemases regardless of the host bacteria, including IMP variants that 172 constitute a very heterogeneous family of enzymes and that are not well detected by most 173 molecular or immunochromatographic assays (46). Our study demonstrated that the Revogene ® 174 Carba C assay is well adapted to the French epidemiology of CPE and CP-Pa which reflects 175 the epidemiology of many European countries. Its simplicity and short turnaround time make 176 it suitable for use in the routine microbiology laboratory. It can provide results from colonies 177 that grew on MH but also from selective screening media. (Table 2) . Among the 40 cultured colonies of A. baumannii 17 produced targeted 206 carbapenemases (1 VIM, 4 IMP, 12 NDM], 10 were none carbapenemase producers, and 13 207 were non-targeted CP-Abs (Table 3) A. baumannii (10) a WT (2) a , GES-11, GES-12, RTG-4, SCO-1, VEB-1 (2), PER-1, OXA-21
Non-targeted carbapenemase producers (13)
A. baumannii ( 
